🕵️ Palisade BIO, Inc. ($PALI)
SEC insider & ownership activity, last 12 months · CIK 1357459 · every row links its SEC filing
Over the last 12 months insiders sold $420K against $268K of open-market buying. Finley John David sold $310K in discretionary trades (Feb–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $268K (8 lots) · 2 sellers, $420K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Finley John David | 0 | – | 2 | $310K | Jul 7, 2026 |
| Baltera Robert Jr. | 6 | $250K | 0 | – | Jul 9, 2026 |
| Jones Mitchell Lawrence | 0 | – | 2 | $110K | Jul 7, 2026 |
| Williams Donald Allen | 2 | $18K | 0 | – | Jan 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 10.0% | 13G | Dec 8, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| Joseph Edelman | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 7.9% | 13G | May 15, 2026 | filing ↗ | |
| Commodore Capital LP | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Commodore Capital Master LP | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Robert Egen Atkinson | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Michael Kramarz | 7.2% | 13G | May 15, 2026 | filing ↗ | |
| Octagon Capital Advisors LP | 6.4% | 13G | Feb 10, 2026 | filing ↗ | |
| Octagon Investments Master Fund LP | 6.4% | 13G | Feb 10, 2026 | filing ↗ | |
| Ting Jia | 6.4% | 13G | Feb 10, 2026 | filing ↗ | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | 13G | Dec 8, 2025 | filing ↗ | |
| Franklin Resources, Inc. | 6.0% | 13G | Jan 29, 2026 | filing ↗ | |
| Franklin Advisers, Inc. | 6.0% | 13G | Jan 29, 2026 | filing ↗ | |
| Soleus Capital Master Fund, L.P. | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Soleus Capital, LLC | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Soleus Capital Group, LLC | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Soleus Capital Management, L.P. | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Soleus GP, LLC | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Guy Levy | 5.4% | 13G | May 27, 2026 | filing ↗ | |
| Ameriprise Financial, Inc. | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| Columbia Management Investment Advisers, LLC | 5.3% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jones Mitchell Lawrence | $108K | Jul 7, 2026 | filing ↗ |
| Finley John David | $303K | Jul 7, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | Mar 27, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 3, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 21, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Oct 15, 2025 | filing ↗ |
| Other events (8.01) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |
| Other events (8.01) | Sep 26, 2025 | filing ↗ |
| Other events (8.01) | Sep 18, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 4, 2025 | filing ↗ |